Urgent Health Advisory: Risks of Counterfeit Botulinum Toxin Injections
The New York State Department of Health has issued an urgent health advisory following reports of 22 adverse incidents across 11 states from botulinum toxin injections using counterfeit products or administered by untrained personnel in non-medical settings. These mishandled injections have led to severe health risks, including symptoms resembling early-stage botulism. Healthcare providers are urged to screen for adverse effects in patients presenting with localized paralysis and report suspected botulism cases within 24 hours. The advisory emphasizes the importance of using only FDA-approved botulinum toxin products and administering them in licensed healthcare facilities. For detailed guidance and contact information, read the full advisory here.
Share
Change Healthcare by Changing Change Healthcare Colleagues: New York City-based NYC Health + Hospitals has made the switch from Change Healthcare to Experian because of the cyberattack on the claims processing vendor. Change turned many of its IT systems offline following the Feb. 21 hack, and that left many hospitals and physician practices unable to […]
-
Federal Investigation into Private Equity, Consolidation in Medicine Three federal agencies are investigating the impact of private equity ownership and the broader consolidation of healthcare organizations on patient care and costs, prompting a wave of concern among physicians. According to Rhonda Wright, MD, from Brookhaven, Georgia, the influence of private equity has led to deteriorating […]
-
MSSNY’s Peer to Peer (P2P) Program Available to Help Stress and burnout among physicians have been documented for years, and can be overwhelming at times. MSSNY’s peer supporters can help you gain a new perspective on your job and other life stressors. MSSNY’s Peer to Peer (P2P) program affords physicians, residents, and medical students the […]
-
Baby Born Deaf Can Hear After Breakthrough Gene Therapy In a landmark advancement in gene therapy, Opal Sandy from Oxfordshire has shown remarkable progress in the global CHORD (Children Hearing and Oral Restoration through DNA) trial, significantly advancing the treatment of auditory neuropathy. This condition disrupts nerve impulses from the inner ear to the brain, […]
